At a recent industry event in London, leaders in private markets sounded a warning: in the U.S. alone, there are now roughly 19,000 private equity funds, outnumbering the ~14,000 McDonald’s outlets across the country. The comparison, while stark, speaks to the crowded landscape and increasing pressure on returns as capital chases fewer standout deals.
The proliferation of funds reflects both decades of growth and a changing risk environment. Rising interest rates, tighter credit markets, and regulatory scrutiny are forcing many firms to compete more aggressively for deals. As one KKR partner put it: “Capital coming back is really important. The mark-to-market paper gains only take you so far.”
This oversupply of funds amplifies the risk of underperformance. More players mean more overlap, higher valuations, and more pressure to deploy capital regardless of deal quality. In many sectors, the competition to win deals is already eroding margins and deal discipline.
For limited partners, the headwinds are mounting as well. With more funds than ever chasing a finite set of opportunities, picking winners becomes more critical — and more difficult. Some investors are increasingly eyeing “zombie” funds that may struggle to raise follow-on capital in weak markets.